Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A stem-cell matrix can repair brain damage in rodents.
After years of controversy, a therapy based on human embryonic stem cells is finally being tested in humans. The treatment holds out hope to paralyzed people, but at how great a risk?
Using RNA instead of DNA could avoid the health risks–and the political pitfalls–of stem-cell treatments.
Replacing certain cells in the retina could slow visual impairment for people with macular degeneration.
Two steps forward and one step back for stem cells, genome sequencing to diagnose disease, and the creation of artificial life.
Scientists get ready for the end of federal restrictions on embryonic-stem-cell research.
Transplanted stem cells restore normal behavior in brain-damaged rodents.
Lungs grown in the lab have been experimentally transplanted into live animals.
The results show that the treatment can be safe, but whether it can be effective is another question.